For a pediatric trauma patient where peripheral intravenous access is not feasible, what is the recommended first‑line intra‑osseous insertion site, appropriate needle size, insertion technique, contraindications, and alternative sites?

Intraosseous Access in Pediatric Trauma Patients

Intraosseous (IO) access is the first-line alternative when peripheral IV access cannot be rapidly obtained in pediatric trauma patients, with the proximal tibia as the primary insertion site. 1, 2

Recommended First-Line IO Insertion Site

The proximal tibia is the primary site for IO access in children under 5 years of age. 2 The insertion point is located 2 cm distal to the tibial tuberosity and 1 cm medial to the tibial plateau on the flat anteromedial surface. 1 Critical caution is required to avoid the epiphyseal growth plate in children to prevent permanent growth disturbances. 1

Alternative Sites

• The humerus is the preferred alternative site when the tibia is unavailable or contraindicated. 1
• Both manual and automated IO devices are available and should be readily accessible to all acute care clinicians. 1

Appropriate Needle Size and Equipment

• Use age-appropriate IO needles: typically 15-18 gauge needles for infants and young children, with length determined by patient size and insertion site. 3
• Both manual insertion devices and automated/powered devices (such as spring-loaded or drill-powered systems) are acceptable and effective. 1
• The choice of device depends on provider training, availability, and clinical context. 1

Insertion Technique

Confirm successful placement by verifying all four criteria: 1

1. Aspiration of bone marrow (note: this is painful in awake patients)
2. Saline flush without extravasation
3. Needle support by the bone cortex
4. Infusion flows under gravity alone

Technical Execution

• Position the needle perpendicular to the bone surface at the designated insertion site. 1
• Apply firm, controlled pressure with a twisting motion (for manual devices) or activate the automated device according to manufacturer instructions. 1
• Once the cortex is penetrated, remove the stylet and immediately confirm placement using the four criteria above. 1
• Secure the device meticulously to prevent dislodgement during patient movement or transport. 1

Medications and Fluids

All intravenous medications can be administered via the IO route with comparable onset and drug levels to IV administration. 1, 2 This includes:

• Epinephrine, adenosine, and all resuscitation medications 1, 2
• Crystalloids, colloids, and blood products 1, 3
• Catecholamines and vasopressors 1
• Antibiotics and other pharmacological agents 3, 4

Administration Technique

• Use manual pressure or an infusion pump for viscous drugs or rapid fluid boluses. 1
• Follow each medication with a saline flush to promote entry into the central circulation. 1
• Blood samples can be obtained for analysis including type and cross-match, but acid-base analysis is inaccurate after sodium bicarbonate administration via the IO cannula. 1

Contraindications

Absolute Contraindications

• Fracture of the target bone (select an alternative site). 1
• Previous IO attempt in the same bone within 24-48 hours due to risk of extravasation through the prior puncture site. 1
• Infection or burn over the insertion site. 1
• Osteogenesis imperfecta or other bone disorders that compromise bone integrity. 1

Relative Contraindications

• Severe osteoporosis (rare in pediatric patients). 1
• Vascular insufficiency in the target extremity. 1

Duration of Use and Removal

Remove the IO device as soon as suitable IV access is established, ideally within 24 hours of placement. 1, 2 Prolonged IO use significantly increases the risk of serious complications including osteomyelitis, compartment syndrome, and fracture. 1, 2

Complications and Monitoring

Monitor continuously for the following complications: 1, 2

• Extravasation (most common complication—presents as swelling around the insertion site)
• Compartment syndrome (requires immediate removal and surgical consultation)
• Fracture (particularly with improper technique or repeated attempts)
• Osteomyelitis and infection (risk increases with duration of use)
• Growth plate injury (can cause permanent limb length discrepancy)
• Pressure necrosis of the skin (from prolonged device placement)

Critical Pitfalls to Avoid

• Do not delay IO placement when peripheral IV access cannot be rapidly obtained—IO access is faster than central venous access and should be the immediate alternative. 1, 5
• Do not leave the IO device in place beyond 24 hours unless absolutely necessary. 1, 2
• Do not attempt IO insertion through infected or burned skin unless it is a true last-resort emergency. 1
• Do not make multiple attempts in the same bone—select an alternative site after one failed attempt. 1

Clinical Context and Evidence

The use of IO access in pediatric trauma is supported by extensive clinical experience showing it is rapid, safe, and effective. 3, 6 Studies demonstrate successful IO placement in 88-93% of attempts, with the tibia being the most commonly used and successful site. 3 In pediatric trauma patients requiring IO access, these tend to be younger (1-6 years), more severely injured children with higher injury severity scores. 6 The American Heart Association designates IO access as a Class I recommendation (useful and effective) for initial vascular access in cases of cardiac arrest when peripheral IV access cannot be rapidly obtained. 1